Role of Pyruvate Kinase M2-mediated Metabolic Reprogramming During Podocyte Differentiation

Overview

Journal Cell Death Dis

Specialties Cell Biology
General Medicine

Date 2020 May 13

PMID 32393782

Citations 31

Authors

Qi Yuan

Jiao Miao

Qianqian Yang

Li Fang

Yi Fang

Hao Ding

Yang Zhou

Lei Jiang

Chunsun Dai

Ke Zen

Qi Sun

Junwei Yang

Affiliations

Soon will be listed here.

Abstract

Podocytes, a type of highly specialized epithelial cells, require substantial levels of energy to maintain glomerular integrity and function, but little is known on the regulation of podocytes' energetics. Lack of metabolic analysis during podocyte development led us to explore the distribution of mitochondrial oxidative phosphorylation and glycolysis, the two major pathways of cell metabolism, in cultured podocytes during in vitro differentiation. Unexpectedly, we observed a stronger glycolytic profile, accompanied by an increased mitochondrial complexity in differentiated podocytes, indicating that mature podocytes boost both glycolysis and mitochondrial metabolism to meet their augmented energy demands. In addition, we found a shift of predominant energy source from anaerobic glycolysis in immature podocyte to oxidative phosphorylation during the differentiation process. Furthermore, we identified a crucial metabolic regulator for podocyte development, pyruvate kinase M2. Pkm2-knockdown podocytes showed dramatic reduction of energy metabolism, resulting in defects of cell differentiation. Meanwhile, podocyte-specific Pkm2-knockout (KO) mice developed worse albuminuria and podocyte injury after adriamycin treatment. We identified mammalian target of rapamycin (mTOR) as a critical regulator of PKM2 during podocyte development. Pharmacological inhibition of mTOR potently abrogated PKM2 expression and disrupted cell differentiation, indicating the existence of metabolic checkpoint that need to be satisfied in order to allow podocyte differentiation.

Citing Articles

Podocyte SIRPα reduction in diabetic nephropathy aggravates podocyte injury by promoting pyruvate kinase M2 nuclear translocation.

Chen Y, Zhang M, Jia R, Qian B, Jing C, Zeng C Redox Biol. 2024; 78:103439.

PMID: 39586122 PMC: 11625355. DOI: 10.1016/j.redox.2024.103439.

ATP dynamics as a predictor of future podocyte structure and function after acute ischemic kidney injury in female mice.

Takahashi M, Yamamoto S, Yamamoto S, Okubo A, Nakagawa Y, Kuwahara K Nat Commun. 2024; 15(1):9977.

PMID: 39578451 PMC: 11584722. DOI: 10.1038/s41467-024-54222-0.

Sex-specific molecular signature of mouse podocytes in homeostasis and in response to pharmacological challenge with rapamycin.

Al-Diab O, Sunkel C, Blanc E, Catar R, Ashraf M, Zhao H Biol Sex Differ. 2024; 15(1):72.

PMID: 39278930 PMC: 11404044. DOI: 10.1186/s13293-024-00647-7.

Visualizing metabolic regulation using metabolic biosensors during sea urchin embryogenesis.

Furze A, Waldron A, Yajima M Dev Biol. 2024; 516:122-129.

PMID: 39117030 PMC: 11402557. DOI: 10.1016/j.ydbio.2024.08.003.

Sanguinarine Induces Necroptosis of HCC by Targeting PKM2 Mediated Energy Metabolism.

Kong R, Wang N, Zhou C, Zhou Y, Guo X, Wang D Cancers (Basel). 2024; 16(14).

PMID: 39061173 PMC: 11274805. DOI: 10.3390/cancers16142533.

References

Garg P . A Review of Podocyte Biology. Am J Nephrol. 2018; 47 Suppl 1:3-13. DOI: 10.1159/000481633. View

Assady S, Wanner N, Skorecki K, Huber T . New Insights into Podocyte Biology in Glomerular Health and Disease. J Am Soc Nephrol. 2017; 28(6):1707-1715. PMC: 5461807. DOI: 10.1681/ASN.2017010027. View

Pavenstadt H, Kriz W, Kretzler M . Cell biology of the glomerular podocyte. Physiol Rev. 2002; 83(1):253-307. DOI: 10.1152/physrev.00020.2002. View

Huber T, Benzing T . The slit diaphragm: a signaling platform to regulate podocyte function. Curr Opin Nephrol Hypertens. 2005; 14(3):211-6. DOI: 10.1097/01.mnh.0000165885.85803.a8. View

Vaughan M, Pippin J, Griffin S, Krofft R, Fleet M, Haseley L . ATRA induces podocyte differentiation and alters nephrin and podocin expression in vitro and in vivo. Kidney Int. 2005; 68(1):133-44. DOI: 10.1111/j.1523-1755.2005.00387.x. View

He J, Lu T, Fleet M, Sunamoto M, Husain M, Fang W . Retinoic acid inhibits HIV-1-induced podocyte proliferation through the cAMP pathway. J Am Soc Nephrol. 2006; 18(1):93-102. PMC: 3197239. DOI: 10.1681/ASN.2006070727. View

Trefely S, Wellen K . Metabolite regulates differentiation. Science. 2018; 360(6389):603-604. DOI: 10.1126/science.aat6663. View

Folmes C, Dzeja P, Nelson T, Terzic A . Metabolic plasticity in stem cell homeostasis and differentiation. Cell Stem Cell. 2012; 11(5):596-606. PMC: 3593051. DOI: 10.1016/j.stem.2012.10.002. View

Agostini M, Romeo F, Inoue S, Niklison-Chirou M, Elia A, Dinsdale D . Metabolic reprogramming during neuronal differentiation. Cell Death Differ. 2016; 23(9):1502-14. PMC: 5072427. DOI: 10.1038/cdd.2016.36. View

10.

Drehmer D, de Aguiar A, Brandt A, Petiz L, Cadena S, Rebelatto C . Metabolic switches during the first steps of adipogenic stem cells differentiation. Stem Cell Res. 2016; 17(2):413-421. DOI: 10.1016/j.scr.2016.09.001. View

11.

Gucer S, Talim B, Asan E, Korkusuz P, Ozen S, Unal S . Focal segmental glomerulosclerosis associated with mitochondrial cytopathy: report of two cases with special emphasis on podocytes. Pediatr Dev Pathol. 2005; 8(6):710-7. DOI: 10.1007/s10024-005-0058-z. View

12.

Markowitz G, Appel G, Fine P, Fenves A, Loon N, Jagannath S . Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. J Am Soc Nephrol. 2001; 12(6):1164-1172. DOI: 10.1681/ASN.V1261164. View

13.

Anastasiou D, Yu Y, Israelsen W, Jiang J, Boxer M, Hong B . Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis. Nat Chem Biol. 2012; 8(10):839-47. PMC: 3711671. DOI: 10.1038/nchembio.1060. View

14.

Palsson-McDermott E, Curtis A, Goel G, Lauterbach M, Sheedy F, Gleeson L . Pyruvate kinase M2 regulates Hif-1α activity and IL-1β induction and is a critical determinant of the warburg effect in LPS-activated macrophages. Cell Metab. 2015; 21(1):65-80. PMC: 5198835. DOI: 10.1016/j.cmet.2014.12.005. View

15.

Dong G, Mao Q, Xia W, Xu Y, Wang J, Xu L . PKM2 and cancer: The function of PKM2 beyond glycolysis. Oncol Lett. 2016; 11(3):1980-1986. PMC: 4774429. DOI: 10.3892/ol.2016.4168. View

16.

Mazurek S, Grimm H, Boschek C, Vaupel P, Eigenbrodt E . Pyruvate kinase type M2: a crossroad in the tumor metabolome. Br J Nutr. 2002; 87 Suppl 1:S23-9. View

17.

Yang W, Zheng Y, Xia Y, Ji H, Chen X, Guo F . ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect. Nat Cell Biol. 2012; 14(12):1295-304. PMC: 3511602. DOI: 10.1038/ncb2629. View

18.

Li T, Han J, Jia L, Hu X, Chen L, Wang Y . PKM2 coordinates glycolysis with mitochondrial fusion and oxidative phosphorylation. Protein Cell. 2019; 10(8):583-594. PMC: 6626593. DOI: 10.1007/s13238-019-0618-z. View

19.

Qi W, Keenan H, Li Q, Ishikado A, Kannt A, Sadowski T . Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction. Nat Med. 2017; 23(6):753-762. PMC: 5575773. DOI: 10.1038/nm.4328. View

20.

Kajiyama H, Titus S, Austin C, Chiotos K, Matsumoto T, Sakairi T . Tetracycline-inducible gene expression in conditionally immortalized mouse podocytes. Am J Nephrol. 2008; 29(3):153-63. PMC: 2698022. DOI: 10.1159/000151770. View